Skip to main content
Journal of Basic and Clinical Pharmacy logoLink to Journal of Basic and Clinical Pharmacy
. 2010 Nov 15;1(4):209–213.

MIDAZOLAM PREMEDICATION IN ATTENUATING KETAMINE PSYCHIC SEQUELAE

S C Somashekara 1,*, D Govindadas 1, G Devashankaraiah 1, Rajkishore Mahato 1, S Deepalaxmi 2, V Srinivas 3, J V Murugesh 3, Devanand 4
PMCID: PMC3979212  PMID: 24825990

Abstract

The objective of the study was to evaluate the effectiveness of midazolam premedication in attenuating the psychic sequelae of ketamine dissociative anaesthesia. Sixty patients undergoing various short surgical and urological procedures were taken in the study. All patients were premedicated with midazolam (0.05mg/kg i.v) five minutes before ketamine induction (1mg/kg i.v). The excitatory phenomenon, emergence delirium, occurrence of unpleasant dreams and patient acceptability of ketamine anaesthesia were recorded. Out of 60 patients studied, 15% had excitatory effects, 8% had mild delirium and 3% patients had unpleasant dreams in post operative period. Patient acceptability of ketamine anaesthesia was 100%. Hence from the study it was concluded that, midazolam premedication is effective in attenuating ketamine psychic sequelae

Keywords: Ketamine, Midazolam, Preaneasthetic medication, Dissociative anaesthesia

Full Text

The Full Text of this article is available as a PDF (316.4 KB).


Articles from Journal of Basic and Clinical Pharmacy are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES